Product
QLP2117
1 clinical trial
1 indication
Indication
CancerClinical trial
A Study Evaluates the Safety, Pharmacokinetics, Immunogenicity and Efficacy of QLP2117 in Advanced Solid Tumor PatientsStatus: Not yet recruiting, Estimated PCD: 2025-04-30